Toward genomic based personalized mathematical models for breast cancer tumor growth

Proceedings - IEEE 14th International Conference on Bioinformatics and Bioengineering, BIBE 2014

Volumn , Issue , 2014, Pages 115-119

  Saribudak, Aydin ^a   Ganic, Emir ^b   Zou, Jianmin ^a   Gundry, Stephen ^a   Uyar, M Ümit ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b City College of New York   (United States)

Author keywords

Breast cancer; Exponential linear model; Gene expressions; I SPY 1; Microarray data; Tumor growth models

Indexed keywords

BIOINFORMATICS; CELL CULTURE; DISEASES; GENES; TUMORS; VOLUME MEASUREMENT;

BREAST CANCER; BREAST CANCER TUMORS; CLINICAL INFORMATION; GENOMIC INFORMATION; LINEAR MODELING; MICROARRAY DATA; TUMOR GROWTH MODELING; TUMOR GROWTH MODELS;

GENE EXPRESSION;

EID: 84939494226     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBE.2014.50     Document Type: Conference Paper

References (28)

1. NBIA-National Biomedical Imaging Archive. National Institutes of Health, https://imaging. nci. nih. gov/ncia.
2. M. Allinen, R. Beroukhim, L. Cai, C. Brennan, J. Lahti-Domenici, H. Huang, D. Porter, M. Hu, L. Chin, A. Richardson, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer cell, 6(1):17-32, 2004.
3. L. Bueno, D. P. de Alwis, C. Pitou, J. Yingling, M. Lahn, S. Glatt, and I. F. Troćoniz. Semi-mechanistic modelling of the tumour growth inhibitory effects of ly2157299, a new type i receptor tgf-? kinase antagonist, in mice. European journal of cancer, 44(1):142-150, 2008.
4. C. S. Cooper, C. Campbell, and S. Jhavar. Mechanisms of disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nature Reviews Urology, 4(12):677-687, 2007.
5. J. Dem?sar. Statistical comparisons of classifiers over multiple data sets. The Journal of Machine Learning Research, 7:1-30, 2006.
6. R. Edgar, M. Domrachev, and A. E. Lash. Gene expression omnibus: Ncbi gene expression and hybridization array data repository. Nucleic acids research, 30(1):207-210, 2002.
7. L. J. Esserman, D. A. Berry, M. C. Cheang, C. Yau, C. M. Perou, L. Carey, A. DeMichele, J. W. Gray, K. Conway-Dorsey, M. E. Lenburg, et al. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the i-spy 1 trial (calgb 150007/150012; acrin 6657). Breast cancer research and treatment, 132(3):1049-1062, 2012.
8. L. J. Esserman, D. A. Berry, A. DeMichele, L. Carey, S. E. Davis, M. Buxton, C. Hudis, J. W. Gray, C. Perou, C. Yau, et al. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the i-spy 1 trialcalgb 150007/150012, acrin 6657. Journal of Clinical Oncology, 30(26):3242-3249, 2012.
9. E. Ganic, S. Gundry, J. Zou, and M. U. Uyar. Evaluation of anti-cancer therapy using in silico analysis of treatments for HER2+ breast cancer. In IEEE Intl. Symposium on Medical Measurements and Applications (MeMeA 2014), pages 211-216, Lisbon, Portugal, June, 2014.
10. S. Gruvberger, M. Ringnér, Y. Chen, S. Panavally, L. H. Saal, A?. Borg, M. Fernö, C. Peterson, and P. S. Meltzer. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer research, 61(16):5979-5984, 2001.
11. S. Gundry, J. Zou, E. Urrea, C. Sahin, J. Kusyk, and M. Uyar. Analysis of emergent behavior for ga-based topology control mechanism for self-spreading nodes in MANETs. In Advances in Intelligent Modelling and Simulation, volume 422 of Studies in Computational Intelligence, pages 155-183. Springer Berlin Heidelberg, 2012.
12. G. P. Gupta, D. X. Nguyen, A. C. Chiang, P. D. Bos, J. Y. Kim, C. Nadal, R. R. Gomis, K. Manova-Todorova, and J. Massagúe. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature, 446(7137):765-770, 2007.
13. M. D. Johnston, C. M. Edwards, W. F. Bodmer, P. K. Maini, and S. J. Chapman. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proceedings of the National Academy of Sciences, 104(10):4008-4013, 2007.
14. M. V. Karamouzis and A. G. Papavassiliou. Tackling the cancer signal transduction "labyrinth" a combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defect. Cancer, 120(3):316-322, 2014.
15. J. Karr, J. Sanghvi, D. Macklin, M. Gutschow, J. Jacobs, J. Bolival, Benjamin, N. Assad-Garcia, J. Glass, and M. Covert. A whole-cell computational model predicts phenotype from genotype. Cell, 150(2).
16. G. Koch, A. Walz, G. Lahu, et al. Modeling of tumor growth and anticancer effects of combination therapy. Journal of Pharmacokinetcs and Pharmacodynamics, 36:179-197, 2009.
17. J. Kusyk, C. Sahin, M. Uyar, E. Urrea, and S. Gundry. Self organization of nodes in mobile ad hoc networks using evolutionary games and genetic algorithms. Journal of Advanced Research, 2(3):253-264, 2011.
18. P. I. Louangrath. Correlation coefficient according to data classification. Available at SSRN 2417910, 2014.
19. X.-J. Ma, S. Dahiya, E. Richardson, M. Erlander, and D. C. Sgroi. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res, 11(1):R7, 2009.
20. A. J. Minn, G. P. Gupta, P. M. Siegel, P. D. Bos, W. Shu, D. D. Giri, A. Viale, A. B. Olshen, W. L. Gerald, and J. Massagúe. Genes that mediate breast cancer metastasis to lung. Nature, 436(7050):518-524, 2005.
21. C. S. Sahin, S. Gundry, and M. U. Uyar. Markov chain analysis of selforganizing mobile nodes. Journal of Intelligent and Robotic Systems, 67:133-153, 2012.
22. M. Simeoni, P. Magni, C. Cammia, et al. Predictive pharmacokinetic pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Research, 64:1094-1101, 2004.
23. C. Sotiriou, S.-Y. Neo, L. M. McShane, E. L. Korn, P. M. Long, A. Jazaeri, P. Martiat, S. B. Fox, A. L. Harris, and E. T. Liu. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences, 100(18):10393-10398, 2003.
24. B. Tran and P. L. Bedard. Luminal-b breast cancer and novel therapeutic targets. Breast Cancer Research, 13(6):221, 2011.
25. E. M. Van Allen, N. Wagle, and M. A. Levy. Clinical analysis and interpretation of cancer genome data. Journal of Clinical Oncology, 31(15):1825-1833, 2013.
26. L. J. van't Veer, H. Dai, M. J. Van De Vijver, et al. Gene expression profiling predicts clinical outcome of breast cancer. nature, 415(6871):530-536, 2002.
27. A. J. Wood, W. E. Evans, and H. L. McLeod. Pharmacogenomics drug disposition, drug targets, and side effects. New England Journal of Medicine, 348(6):538-549, 2003.
28. J. Zou, S. Gundry, E. Ganic, and M. U. Uyar. Mathematical models for absorption and efficacy of ovarian cancer treatments. In Proc. 36th IEEE Eng. in Medicine and Biology Society Conf. (EMBC), pages 3442-3445, August, 2014.